← Back to Patent Explorer
US4656161A Expired / Lapsed US ⏱️ 0.0 years remaining

Increasing the enteral absorbability of heparin or heparinoids

Assignee: BASF SE
•
Filing: 1984-08-27
•
Granted: 1987-04-07
•
Expires: 2004-08-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An enterally absorbable heparin or heparinoid preparation contains a non-ionic surfactant.

Inventors

  • 👤 Dieter Herr

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 10:31
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/14; A61K47/26; A61K9/00; A61K9/48; A61K9/4841; A61K9/4858; A61P; A61P7/00; A61P7/02

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 85 words
A method of preventing thrombosis and for inhibiting blood coagulation in a patient which comprises: orally administering to the patient an effective amount of a composition which consists essentially of heparin having a molecular weight of from 1,200 to about 30,000 as the active agent, at least about 0.2 part by weight of a physiologically tolerated non-ionic surfactant per part by weight of heparin and a pharmaceutically acceptable carrier and/or diluent said surfactant prepared by reacting ethylene oxide with a fatty alcohol or an alkylphenol.
Claim 2
Independent Claim 85 words
A method of preventing thrombosis and for inhibiting blood coagulation in a patient which comprises: orally administering to the patient an effective amount of a composition which consists essentially of heparin having a molecular weight of from 1,200 to about 30,000 as the active agent, at least about 0.2 part by weight of a physiologically tolerated non-ionic surfactant per part by weight of heparin and a pharmaceutically acceptable carrier and/or diluent said surfactant prepared by reacting ethylene oxide with a fatty alcohol or an alkylphenol.
Claim 3
Dependent Claim 65 words
The method of claim 1, wherein the surfactant has the formula R--[(CH.sub.2).sub.n --O].sub.m --H I where R is alkoxy, alkylaryloxy, acylamino or acyloxy, each of 4 to 22 carbon atoms, or an acylated sorbitan or glycerol radical where the acyl radical is of 4 to 22 carbon atoms, n is an integer from 2 to 6 and m is an integer from 1 to 200.
Claim 4
Dependent Claim 34 words
The method of claim 2, wherein R is a hydrocarbon radical of 7 to 18 carbons containing 1 or more double bonds, n is 2 or 3 and m is from 10 to 100.
Claim 5
Dependent Claim 23 words
The method of claim 1, wherein the daily amount of the composition administered to the patient is from about 50 to 5000 IU/kg.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-04-06 1990-10-06 1991-04-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-04-06 1994-10-06 1995-04-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-04-06 1998-10-06 1999-04-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag